Impact of Opioid Epidemic on Infective Endocarditis Outcomes in the United States: From the National Readmission Database
Authors:
- 7 September 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 183, 137-142
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United StatesMayo Clinic Proceedings, 2020
- Geographic Trends, Patient Characteristics, and Outcomes of Infective Endocarditis Associated With Drug Abuse in the United States From 2002 to 2016Journal of the American Heart Association, 2019
- Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission DatabaseJournal of the American Heart Association, 2019
- Clinical Outcomes of Infective Endocarditis in Injection Drug UsersJACC, 2019
- Changes in the Association of Rising Infective Endocarditis With Mortality in People Who Inject DrugsJAMA Cardiology, 2018
- The Cardiovascular Effects of CocaineJACC, 2017
- Quality of Care of Hospitalized Infective Endocarditis Patients: Report from a Tertiary Medical CenterJournal of Hospital Medicine, 2017
- Increasing Infectious Endocarditis Admissions Among Young People Who Inject DrugsOpen Forum Infectious Diseases, 2016
- Infective Endocarditis in Patients with Human Immunodeficiency Virus InfectionJournal of Infection, 2001
- Impact of Highly Active Antiretroviral Therapy in HIV-positive Patients with Cardiac InvolvementJournal of Infection, 2000